Biogen Pharmachem Industries Limited has announced the Annual Secretarial Compliance Report for the financial year 2024-25, prepared by KH & Associates, Practicing Company Secretaries.

The report confirms full compliance with applicable SEBI regulations and circulars, with no violations or actions taken by SEBI or stock exchanges against the company or its directors.

Key governance practices including policy adoption, website disclosures, related party transactions, and board evaluations are properly maintained.

No director disqualifications or significant non-compliances were noted, reflecting sound regulatory adherence and corporate governance standards.